Evidence map›Paper›PMID 24818994›Full record

ArticlePloS one2014

The S. pombe translation initiation factor eIF4G is Sumoylated and associates with the SUMO protease Ulp2.

Jirapas Jongjitwimol, Min Feng, Lihong Zhou, Oliver Wilkinson, Lauren Small, Robert Baldock, Deborah L Taylor, Duncan Smith, Lucas D Bowler, Simon J Morley and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Jirapas JongjitwimolGenome Damage and Stability Centre, School of Life Sciences, University of Sussex, Falmer, Brighton, United Kingdom.
Min FengGenome Damage and Stability Centre, School of Life Sciences, University of Sussex, Falmer, Brighton, United Kingdom.
Lihong ZhouGenome Damage and Stability Centre, School of Life Sciences, University of Sussex, Falmer, Brighton, United Kingdom.
Oliver WilkinsonGenome Damage and Stability Centre, School of Life Sciences, University of Sussex, Falmer, Brighton, United Kingdom.
Lauren SmallGenome Damage and Stability Centre, School of Life Sciences, University of Sussex, Falmer, Brighton, United Kingdom.
Robert BaldockGenome Damage and Stability Centre, School of Life Sciences, University of Sussex, Falmer, Brighton, United Kingdom.
Deborah L TaylorGenome Damage and Stability Centre, School of Life Sciences, University of Sussex, Falmer, Brighton, United Kingdom.
Duncan SmithPaterson Institute for Cancer Research, The University of Manchester, Manchester, United Kingdom.
Lucas D BowlerGenome Damage and Stability Centre, School of Life Sciences, University of Sussex, Falmer, Brighton, United Kingdom.
Simon J MorleyBiochemistry and Biomedical Sciences, School of Life Sciences, University of Sussex, Falmer, Brighton, United Kingdom.
Felicity Z WattsGenome Damage and Stability Centre, School of Life Sciences, University of Sussex, Falmer, Brighton, United Kingdom.
University of Sussex · GBCancer Research UK Manchester Institute · GB

Funding

Biotechnology and Biological Sciences Research CouncilCancer Research UK 11978Medical Research Council G0500308
6 · The paper itself

Abstract

SUMO is a small post-translational modifier, that is attached to lysine residues in target proteins. It acts by altering protein-protein interactions, protein localisation and protein activity. SUMO chains can also act as substrates for ubiquitination, resulting in proteasome-mediated degradation of the target protein. SUMO is removed from target proteins by one of a number of specific proteases. The processes of sumoylation and desumoylation have well documented roles in DNA metabolism and in the maintenance of chromatin structure. To further analyse the role of this modification, we have purified protein complexes containing the S. pombe SUMO protease, Ulp2. These complexes contain proteins required for ribosome biogenesis, RNA stability and protein synthesis. Here we have focussed on two translation initiation factors that we identified as co-purifying with Ulp2, eIF4G and eIF3h. We demonstrate that eIF4G, but not eIF3h, is sumoylated. This modification is increased under conditions that produce cytoplasmic stress granules. Consistent with this we observe partial co-localisation of eIF4G and SUMO in stressed cells. Using HeLa cells, we demonstrate that human eIF4GI is also sumoylated; in vitro studies indicate that human eIF4GI is modified on K1368 and K1588, that are located in the C-terminal eIF4A- and Mnk-binding sites respectively.

Indexed as

EndopeptidasesEukaryotic Initiation Factor-4GHeLa CellsHumansSchizosaccharomycesSchizosaccharomyces pombe ProteinsSumoylationEndopeptidasesEukaryotic Initiation Factor-4GSchizosaccharomyces pombe Proteins

Identifiers

PMID24818994
PMCPMC4018355
OpenAlexW1968538689

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.